World Enzyme-Linked Immunosorbent Assay (ELISA) Industry

  • January 2015
  • -
  • Global Industry Analysts
  • -
  • 279 pages

This report analyzes the worldwide markets for Enzyme-Linked Immunosorbent Assay (ELISA) in US$ Thousands by the following Product Segments: ELISA Development Sets and Antibody Pairs, and ELISA Kits. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 123 companies including many key and niche players such as -

American Laboratory Products Company
BD Biosciences
BioMérieux SA
Bio-Rad Laboratories, Inc.
EMD Millipore, Corp.

Table Of Contents

World Enzyme-Linked Immunosorbent Assay (ELISA) Industry



I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-2
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
ELISA Development Sets and Antibody Pairs I-3
ELISA Kits I-3


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
ELISA - A Renowned and Proven Assay Format II-1
Current and Future Analysis II-1
Factors Sustaining Market II-2
Factors Restraining Growth II-2
ELISA amid A Challenging Environment II-2
Strategies to Counter Competition II-3
Technological Advances to buoy ELISA's Prospects II-3
Automation of ELISA - Enabling its Sustenance II-3
Growing Popularity of Multiplexing Deters ELISA Market II-4
Commoditization: A Key Issue Facing ELISA Product Manufacturers II-4
Limited ELISA Application in the Food Industry II-5
Available Test Kits at External Laboratories by Allergen II-5
Competitive Landscape II-5
ELISA Products of Select Manufacturers II-6
Select Recent Innovations in Elisa II-7
Autoantigen Innovation Enhances Autoimmune Disease Prognosis II-7
Double-Antibody Sandwich ELISA for West Nile Virus Detection II-7
Direct Competitive ELISA in Detection of Mycoplasma bovis
Infection II-8

2. IMMUNOCHEMISTRY - AN INTRODUCTION II-9
Overview II-9
Comparison of Various Immunoassay Technologies II-9
Table 1: Global Immunoassay Instruments Market by Product
(2013): Percentage Breakdown of Revenue for CLIA, EIA,
Enzyme-linked Fluorescent Systems, Immunofluorescence
Analyzers, Multiplex Assays, and RIA (includes corresponding
Graph/Chart) II-10

3. PRODUCT OVERVIEW II-11
Enzyme-Linked Immunosorbent Assay (ELISA) - An Introduction II-11
ELISA Technique II-11
Steps in ELISA Technique II-11
Testing for Proteins II-12
History II-12
Types of ELISA II-12
Indirect ELISA II-12
Drawbacks II-13
Sandwich ELISA II-13
Advantages II-14
Competitive ELISA II-14
Reverse ELISA II-14
Advantages II-15
Research ELISA Market II-15
ELISA Development Sets and Antibody Pairs II-15
ELISA Kits II-15
Applications of ELISA II-15
ELISA in HIV II-16

4. PRODUCT INNOVATIONS/INTRODUCTIONS II-17
Bioo Scientific Introduces Quinolone Residue Detection Kits II-17
BioPorto Diagnostics Launches New ELISA Kit II-17
Epitope Launches ACTH ELISA Kit II-17
Crystal Chem Launches C-Peptide Kit II-17
Protagen Introduces ELISA Kit for Systemic Sclerosis II-17
Epitope Diagnostics Launches ELISA Kits and Anti-auristatin mAbs II-17
IDEXX Introduces ELISA for Whipworm Antigen Detection II-17
apDia Launches CE-Marked ELISA II-18
INOVA Diagnostics Launches QUANTA Lite II-18
Eagle Biosciences Launches Two ELISA Assays II-18
Eagle Biosciences Introduces Homoarginine ELISA II-18
Affinity Biologicals Launches Polyclonal Antibody ELISA Kit II-18
Enzo Introduces Alzheimer's ELISA Kit II-18
Diagnostica Stago Introduces Cy-Quant VASP/P2Y12 II-18
Corgenix to Launch Hepcidin-25 ELISA II-19
ViroGates Introduces suparnostic® ELISA Kit II-19
Convergent Technologies Launches Convergys® ELISA Reagents II-19
Kem-En-Tec Launches ECO-TEK Product Line II-19
Mercodia Launches Glucagon ELISA II-19
Abcam Plc Launches SimpleStep ELISA Kits II-19
Salimetrics Introduces ELISA Kit for Interleukin-6 II-19
Randox Unveils ELISA for Detection of Next-Generation
Synthetic Cannabinoids II-20
Romer Unveils New AgraQuant® Cashew Elisa II-20
Neogen Unveils New Spice ELISA Test II-20
Randox Unveils Three Elisa Test Kits II-20
Enzo Introduces New Hydroxycholesterol ELISA Kit II-20
Icosagen Unveils CDNF ELISA KIT II-20
Randox Launches New ELISA Tests for Detection of Bath Salts II-20
Pribo Lab Unveils New Melamine Elisa Kit II-21
Alpco Unveils New Human Osteopontin ELISA II-21
Eagle Launches New Vitamin Assay Kits II-21
Eagle Launches New Catecholamine ELISA Assays Kits II-21
Romer Unveils Two AgraQuant® ELISA Kits II-21
Alpco Unveils STELLUX Chemiluminescent ELISA II-21
AnaSpec Launches SensoLyte® ELISA Kits II-21
Stellar Biotechnologies Introduces Stellar KLHâ„¢ ELISA Test Kits II-22
Alpco Diagnostics Introduces Mouse Sclerostin ELISA II-22
Neurotune Unveils NTCAF ELISA II-22
Eagle Biosciences Launches 25-OH Vitamin D ELISA II-22
Pro-Lab Diagnostics Unveils Prolisa Cryptosporidium/Giardia
EIA Kit II-22
Bioo Scientific Introduces Two MaxSignal® Aflatoxin M1 ELISA Kits II-22

5. RECENT INDUSTRY ACTIVITY II-23
Orgentec Acquires Corgenix II-23
USDA Approves Swine Influenza ELISA by IDEXX II-23
Euro Diagnostica and Dako Enter Partnership II-23
DSI and Dynex Enter Distribution Agreement II-23
Dynex Obtains SFDA Approval for DSX® ELISA Processing System II-23
Immuno-Biological Laboratories Inks Agreement with WILEX II-23
Argutus Medical Changes Name to EKF Diagnostics Ltd. II-24
Wilex Signs Distribution Agreement with GeneDiagnostics II-24
BioTez Selects Eagle Biosciences as Exclusive Distributor in
North America II-24
Biohit Inks Distribution Agreement with Gold Standard Diagnostics II-24
Bio-Rad Acquires Antibody Manufacturer AbD Serotec II-24
Aushon BioSystems Inks Distribution Agreement with AH Diagnostics II-24
IBT Signs an Exclusive Distribution Agreement with Eagle
Biosciences II-24
Life Technologies Enters into Partnership with Sino Biological II-25
Avioq Gets FDA Approval for HTLV-I/II Microelisa System II-25
Bio-Rad Obtains FDA Premarket Application Approval for GS HIV
Combo Ag/Ab EIA II-25
Thermo Fisher Sets-Up a Molecular Biology Center of Excellence
in Lithuania II-25
ZEUS Receives FDA Clearance for ZEUS ELISAâ„¢ II-25
Dynex Inks Supply Deal with Techlab® II-25
One Lambda Complete a Supply Agreement with CellTrend II-25
Dynex Inks Supply Deal with Zeus II-25

6. FOCUS ON SELECT PLAYERS II-26
American Laboratory Products Company (ALPCO) (US) II-26
BD Biosciences (US) II-26
BioMerieux SA (France) II-26
Bio-Rad Laboratories, Inc. (US) II-27
EMD Millipore, Corp. (US) II-28
Ortho-Clinical Diagnostics, Inc. (US) II-28
RandD Systems, Inc. (US) II-29
Thermo Fisher Scientific, Inc. (US) II-29
Life Technologies Corporation (US) II-30
ZEUS Scientific, Inc. (US) II-31

7. GLOBAL MARKET PERSPECTIVE II-32
Analysis by Region II-32
Table 2: World Recent Past, Current and Future Analysis for
Research ELISA by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) II-32

Table 3: World Historic Review for Research ELISA by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
Latin America and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) II-33

Table 4: World 15-Year Perspective for Research ELISA by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific, Latin America and
Rest of World Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) II-34
Analysis by Segment II-35
Table 5: World Recent Past, Current and Future Analysis for
ELISA Development Sets and Antibody Pairs by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific, Latin
America and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) II-35

Table 6: World Historic Review for ELISA Development Sets and
Antibody Pairs by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-36

Table 7: World 15-Year Perspective for ELISA Development Sets
and Antibody Pairs by Geographic Region - Percentage
Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) II-37

Table 8: World Recent Past, Current and Future Analysis for
ELISA Kits by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) II-38

Table 9: World Historic Review for ELISA Kits by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific, Latin
America and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) II-39

Table 10: World 15-Year Perspective for ELISA Kits by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific, Latin America and
Rest of World Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) II-40


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
An Overview of ELISA Usage III-1
Leading Applications of ELISA in the US III-2
Leading Analytes/Samples Analyzed using ELISA in the US III-2
Comparison of ELISA Product Offerings of Select Players:
Depicted by Presence in Product Segments - Reagents, Kits
and Assays; Plate Washers and Coated Microplates III-3
Product Launches III-3
Strategic Corporate Developments III-7
Select Major Players III-9
B.Market Analytics III-14
Table 11: The US Recent Past, Current and Future Analysis for
Research ELISA by Product Segment - ELISA Development Sets
and Antibody Pairs, and ELISA Kits Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-14

Table 12: The US Historic Review for Research ELISA by
Product Segment - ELISA Development Sets and Antibody Pairs,
and ELISA Kits Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-15

Table 13: The US 15-Year Perspective for Research ELISA by
Product Segment - Percentage Breakdown of Dollar Sales for
ELISA Development Sets and Antibody Pairs, and ELISA Kits
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-16

2. CANADA III-17
A.Market Analysis III-17
Current and Future Analysis III-17
ELISA Sees Increasing Use in Detection of Environmental Toxins III-17
Product Launches III-17
B.Market Analytics III-18
Table 14: Canadian Recent Past, Current and Future Analysis
for Research ELISA by Product Segment - ELISA Development
Sets and Antibody Pairs, and ELISA Kits Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-18

Table 15: Canadian Historic Review for Research ELISA by
Product Segment - ELISA Development Sets and Antibody Pairs,
and ELISA Kits Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-19

Table 16: Canadian 15-Year Perspective for Research ELISA by
Product Segment - Percentage Breakdown of Dollar Sales for
ELISA Development Sets and Antibody Pairs, and ELISA Kits
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-20

3. JAPAN III-21
Market Analysis III-21
Table 17: Japanese Recent Past, Current and Future Analysis
for Research ELISA by Product Segment - ELISA Development
Sets and Antibody Pairs, and ELISA Kits Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-21

Table 18: Japanese Historic Review for Research ELISA by
Product Segment - ELISA Development Sets and Antibody Pairs,
and ELISA Kits Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-22

Table 19: Japanese 15-Year Perspective for Research ELISA by
Product Segment - Percentage Breakdown of Dollar Sales for
ELISA Development Sets and Antibody Pairs, and ELISA Kits
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-23

4. EUROPE III-24
Market Analysis III-24
Table 20: European Recent Past, Current and Future Analysis
for Research ELISA by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-25

Table 21: European Historic Review for Research ELISA by
Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-26

Table 22: European 15-Year Perspective for Research ELISA by
Geographic Region - Percentage Breakdown of Dollar Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-27

Table 23: European Recent Past, Current and Future Analysis
for Research ELISA by Product Segment - ELISA Development
Sets and Antibody Pairs, and ELISA Kits Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-28

Table 24: European Historic Review for Research ELISA by
Product Segment - ELISA Development Sets and Antibody Pairs,
and ELISA Kits Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-29

Table 25: European 15-Year Perspective for Research ELISA by
Product Segment - Percentage Breakdown of Dollar Sales for
ELISA Development Sets and Antibody Pairs, and ELISA Kits
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-30

4a. FRANCE III-31
A.Market Analysis III-31
Current and Future Analysis III-31
Biomerieux Sa - A Key Player III-31
B.Market Analytics III-32
Table 26: French Recent Past, Current and Future Analysis for
Research ELISA by Product Segment - ELISA Development Sets
and Antibody Pairs, and ELISA Kits Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-32

Table 27: French Historic Review for Research ELISA by
Product Segment - ELISA Development Sets and Antibody Pairs,
and ELISA Kits Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-33

Table 28: French 15-Year Perspective for Research ELISA by
Product Segment - Percentage Breakdown of Dollar Sales for
ELISA Development Sets and Antibody Pairs, and ELISA Kits
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-34

4b. GERMANY III-35
A.Market Analysis III-35
Current and Future Analysis III-35
Product Launches III-35
Strategic Corporate Developments III-35
B.Market Analytics III-36
Table 29: German Recent Past, Current and Future Analysis for
Research ELISA by Product Segment - ELISA Development Sets
and Antibody Pairs, and ELISA Kits Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-36

Table 30: German Historic Review for Research ELISA by
Product Segment - ELISA Development Sets and Antibody Pairs,
and ELISA Kits Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-37

Table 31: German 15-Year Perspective for Research ELISA by
Product Segment - Percentage Breakdown of Dollar Sales for
ELISA Development Sets and Antibody Pairs, and ELISA Kits
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-38

4c. ITALY III-39
A.Market Analysis III-39
Current and Future Analysis III-39
Strategic Corporate Development III-39
B.Market Analytics III-40
Table 32: Italian Recent Past, Current and Future Analysis for
Research ELISA by Product Segment - ELISA Development Sets
and Antibody Pairs, and ELISA Kits Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-40

Table 33: Italian Historic Review for Research ELISA by
Product Segment - ELISA Development Sets and Antibody Pairs,
and ELISA Kits Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-41

Table 34: Italian 15-Year Perspective for Research ELISA by
Product Segment - Percentage Breakdown of Dollar Sales for
ELISA Development Sets and Antibody Pairs, and ELISA Kits
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-42

4d. THE UNITED KINGDOM III-43
A.Market Analysis III-43
Current and Future Analysis III-43
Product Launches III-43
B.Market Analytics III-44
Table 35: UK Recent Past, Current and Future Analysis for
Research ELISA by Product Segment - ELISA Development Sets
and Antibody Pairs, and ELISA Kits Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-44

Table 36: UK Historic Review for Research ELISA by Product
Segment - ELISA Development Sets and Antibody Pairs, and
ELISA Kits Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-45

Table 37: UK 15-Year Perspective for Research ELISA by
Product Segment - Percentage Breakdown of Dollar Sales for
ELISA Development Sets and Antibody Pairs, and ELISA Kits
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-46

4e. SPAIN III-47
Market Analysis III-47
Table 38: Spanish Recent Past, Current and Future Analysis for
Research ELISA by Product Segment - ELISA Development Sets
and Antibody Pairs, and ELISA Kits Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-47

Table 39: Spanish Historic Review for Research ELISA by
Product Segment - ELISA Development Sets and Antibody Pairs,
and ELISA Kits Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-48

Table 40: Spanish 15-Year Perspective for Research ELISA by
Product Segment - Percentage Breakdown of Dollar Sales for
ELISA Development Sets and Antibody Pairs, and ELISA Kits
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-49

4f. RUSSIA III-50
Market Analysis III-50
Table 41: Russian Recent Past, Current and Future Analysis for
Research ELISA by Product Segment - ELISA Development Sets
and Antibody Pairs, and ELISA Kits Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-50

Table 42: Russian Historic Review for Research ELISA by
Product Segment - ELISA Development Sets and Antibody Pairs,
and ELISA Kits Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-51

Table 43: Russian 15-Year Perspective for Research ELISA by
Product Segment - Percentage Breakdown of Dollar Sales for
ELISA Development Sets and Antibody Pairs, and ELISA Kits
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-52

4g. REST OF EUROPE III-53
A.Market Analysis III-53
Current and Future Analysis III-53
Product Launches III-53
Strategic Corporate Developments III-54
B.Market Analytics III-56
Table 44: Rest of Europe Recent Past, Current and Future
Analysis for Research ELISA by Product Segment - ELISA
Development Sets and Antibody Pairs, and ELISA Kits Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-56

Table 45: Rest of Europe Historic Review for Research ELISA
by Product Segment - ELISA Development Sets and Antibody
Pairs, and ELISA Kits Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-57

Table 46: Rest of Europe 15-Year Perspective for Research
ELISA by Product Segment - Percentage Breakdown of Dollar
Sales for ELISA Development Sets and Antibody Pairs, and
ELISA Kits Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-58

5. ASIA-PACIFIC III-59
Market Analysis III-59
Table 47: Asia-Pacific Recent Past, Current and Future
Analysis for Research ELISA by Geographic Region - China and
Rest of Asia-Pacific Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) III-59

Table 48: Asia-Pacific Historic Review for Research ELISA by
Geographic Region - China and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-60

Table 49: Asia-Pacific 15-Year Perspective for Research
ELISA by Geographic Region - Percentage Breakdown of Dollar
Sales for China and Rest of Asia-Pacific Markets for Years
2006, 2014 and 2020 (includes corresponding Graph/Chart) III-61

Table 50: Asia-Pacific Recent Past, Current and Future
Analysis for Research ELISA by Product Segment - ELISA
Development Sets and Antibody Pairs, and ELISA Kits Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-62

Table 51: Asia-Pacific Historic Review for Research ELISA by
Product Segment - ELISA Development Sets and Antibody Pairs,
and ELISA Kits Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-63

Table 52: Asia-Pacific 15-Year Perspective for Research
ELISA by Product Segment - Percentage Breakdown of Dollar
Sales for ELISA Development Sets and Antibody Pairs, and
ELISA Kits Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-64

5a. CHINA III-65
A.Market Analysis III-65
Current and Future Analysis III-65
Strategic Corporate Developments III-65
B.Market Analytics III-66
Table 53: Chinese Recent Past, Current and Future Analysis for
Research ELISA by Product Segment - ELISA Development Sets
and Antibody Pairs, and ELISA Kits Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-66

Table 54: Chinese Historic Review for Research ELISA by
Product Segment - ELISA Development Sets and Antibody Pairs,
and ELISA Kits Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-67

Table 55: Chinese 15-Year Perspective for Research ELISA by
Product Segment - Percentage Breakdown of Dollar Sales for
ELISA Development Sets and Antibody Pairs, and ELISA Kits
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-68

5b. REST OF ASIA-PACIFIC III-69
A.Market Analysis III-69
Current and Future Analysis III-69
A Peek into the Immunochemistry Market in India III-69
Table 56: Indian Immunochemistry Market by Segment (2013):
Percentage Revenue Breakdown of Immunochemistry Instruments and
Reagents, ELISA Kits, and Rapid Tests (includes
corresponding Graph/Chart) III-69
Product Launches III-70
B.Market Analytics III-71
Table 57: Rest of Asia-Pacific Recent Past, Current and Future
Analysis for Research ELISA by Product Segment - ELISA
Development Sets and Antibody Pairs, and ELISA Kits Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-71

Table 58: Rest of Asia-Pacific Historic Review for Research
ELISA by Product Segment - ELISA Development Sets and
Antibody Pairs, and ELISA Kits Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-72

Table 59: Rest of Asia-Pacific 15-Year Perspective for
Research ELISA by Product Segment - Percentage Breakdown of
Dollar Sales for ELISA Development Sets and Antibody Pairs,
and ELISA Kits Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-73

6. LATIN AMERICA III-74
Market Analysis III-74
Table 60: Latin American Recent Past, Current and Future
Analysis for Research ELISA by Product Segment - ELISA
Development Sets and Antibody Pairs, and ELISA Kits Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-74

Table 61: Latin American Historic Review for Research ELISA
by Product Segment - ELISA Development Sets and Antibody
Pairs, and ELISA Kits Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-75

Table 62: Latin American 15-Year Perspective for Research
ELISA by Product Segment - Percentage Breakdown of Dollar
Sales for ELISA Development Sets and Antibody Pairs, and
ELISA Kits Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-76

7. REST OF WORLD III-77
Market Analysis III-77
Table 63: Rest of World Recent Past, Current and Future
Analysis for Research ELISA by Product Segment - ELISA
Development Sets and Antibody Pairs, and ELISA Kits Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-77

Table 64: Rest of World Historic Review for Research ELISA
by Product Segment - ELISA Development Sets and Antibody
Pairs, and ELISA Kits Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-78

Table 65: Rest of World 15-Year Perspective for Research
ELISA by Product Segment - Percentage Breakdown of Dollar
Sales for ELISA Development Sets and Antibody Pairs, and
ELISA Kits Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-79


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 123 (including Divisions/Subsidiaries - 126)

The United States (76)
Canada (4)
Japan (2)
Europe (35)
- France (1)
- Germany (11)
- The United Kingdom (8)
- Spain (1)
- Rest of Europe (14)
Asia-Pacific (Excluding Japan) (9)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ...

PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

Global Markets for Research Antibodies

Global Markets for Research Antibodies

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering a compound ...

Biosimilars: Global Markets

January 2015 $ 6 650

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.